Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis
M Yang, Y Zhang, H Chen, J Lin, J Zeng, Z Xu - Infection, 2019 - Springer
Background Recent studies have suggested a possible association between respiratory
infection and the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper
respiratory tract infection (URTI) with long-term inhaled corticosteroid use among patients
with asthma. Methods Through a comprehensive literature search of PubMed, Cochrane
Library, EMBASE, and Google Scholar from inception to May 2018, we included randomized
controlled trials of any ICS vs. a control treatment for asthma, with reporting of URTI as an …
infection and the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper
respiratory tract infection (URTI) with long-term inhaled corticosteroid use among patients
with asthma. Methods Through a comprehensive literature search of PubMed, Cochrane
Library, EMBASE, and Google Scholar from inception to May 2018, we included randomized
controlled trials of any ICS vs. a control treatment for asthma, with reporting of URTI as an …
Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease
RH Johnsen, CK Heerfordt, JB Boel… - … open respiratory …, 2023 - bmjopenrespres.bmj.com
Background Use of inhaled corticosteroids (ICS) is common in patients with chronic
obstructive pulmonary disease (COPD) and has been associated with an increased risk of
pneumonia. Moraxella catarrhalis is one of the most common bacterial causes of infectious
exacerbation in COPD. Currently, to our knowledge, no studies have investigated if ICS
increases the risk of lower respiratory tract infection with M. catarrhalis in patients with
COPD. Objective To investigate if accumulated ICS use in patients with COPD, is associated …
obstructive pulmonary disease (COPD) and has been associated with an increased risk of
pneumonia. Moraxella catarrhalis is one of the most common bacterial causes of infectious
exacerbation in COPD. Currently, to our knowledge, no studies have investigated if ICS
increases the risk of lower respiratory tract infection with M. catarrhalis in patients with
COPD. Objective To investigate if accumulated ICS use in patients with COPD, is associated …
以上显示的是最相近的搜索结果。 查看全部搜索结果